401 related articles for article (PubMed ID: 19747917)
1. Natural killer cells are polarized toward cytotoxicity in chronic hepatitis C in an interferon-alfa-dependent manner.
Ahlenstiel G; Titerence RH; Koh C; Edlich B; Feld JJ; Rotman Y; Ghany MG; Hoofnagle JH; Liang TJ; Heller T; Rehermann B
Gastroenterology; 2010 Jan; 138(1):325-35.e1-2. PubMed ID: 19747917
[TBL] [Abstract][Full Text] [Related]
2. Early changes in natural killer cell function indicate virologic response to interferon therapy for hepatitis C.
Ahlenstiel G; Edlich B; Hogdal LJ; Rotman Y; Noureddin M; Feld JJ; Holz LE; Titerence RH; Liang TJ; Rehermann B
Gastroenterology; 2011 Oct; 141(4):1231-9, 1239.e1-2. PubMed ID: 21741920
[TBL] [Abstract][Full Text] [Related]
3. Early changes in interferon signaling define natural killer cell response and refractoriness to interferon-based therapy of hepatitis C patients.
Edlich B; Ahlenstiel G; Zabaleta Azpiroz A; Stoltzfus J; Noureddin M; Serti E; Feld JJ; Liang TJ; Rotman Y; Rehermann B
Hepatology; 2012 Jan; 55(1):39-48. PubMed ID: 21898483
[TBL] [Abstract][Full Text] [Related]
4. Expansion of functionally skewed CD56-negative NK cells in chronic hepatitis C virus infection: correlation with outcome of pegylated IFN-alpha and ribavirin treatment.
Gonzalez VD; Falconer K; Björkström NK; Blom KG; Weiland O; Ljunggren HG; Alaeus A; Sandberg JK
J Immunol; 2009 Nov; 183(10):6612-8. PubMed ID: 19846870
[TBL] [Abstract][Full Text] [Related]
5. Interferon-alpha-induced TRAIL on natural killer cells is associated with control of hepatitis C virus infection.
Stegmann KA; Björkström NK; Veber H; Ciesek S; Riese P; Wiegand J; Hadem J; Suneetha PV; Jaroszewicz J; Wang C; Schlaphoff V; Fytili P; Cornberg M; Manns MP; Geffers R; Pietschmann T; Guzmán CA; Ljunggren HG; Wedemeyer H
Gastroenterology; 2010 May; 138(5):1885-97. PubMed ID: 20334827
[TBL] [Abstract][Full Text] [Related]
6. Cell-to-cell contact with hepatitis C virus-infected cells reduces functional capacity of natural killer cells.
Yoon JC; Lim JB; Park JH; Lee JM
J Virol; 2011 Dec; 85(23):12557-69. PubMed ID: 21937646
[TBL] [Abstract][Full Text] [Related]
7. NK cells from HCV-infected patients effectively induce apoptosis of activated primary human hepatic stellate cells in a TRAIL-, FasL- and NKG2D-dependent manner.
Glässner A; Eisenhardt M; Krämer B; Körner C; Coenen M; Sauerbruch T; Spengler U; Nattermann J
Lab Invest; 2012 Jul; 92(7):967-77. PubMed ID: 22449797
[TBL] [Abstract][Full Text] [Related]
8. Natural killer cell functional dichotomy in chronic hepatitis B and chronic hepatitis C virus infections.
Oliviero B; Varchetta S; Paudice E; Michelone G; Zaramella M; Mavilio D; De Filippi F; Bruno S; Mondelli MU
Gastroenterology; 2009 Sep; 137(3):1151-60, 1160.e1-7. PubMed ID: 19470388
[TBL] [Abstract][Full Text] [Related]
9. Rapid decrease in hepatitis C viremia by direct acting antivirals improves the natural killer cell response to IFNα.
Serti E; Park H; Keane M; O'Keefe AC; Rivera E; Liang TJ; Ghany M; Rehermann B
Gut; 2017 Apr; 66(4):724-735. PubMed ID: 26733671
[TBL] [Abstract][Full Text] [Related]
10. Cirrhosis Hampers Early and Rapid Normalization of Natural Killer Cell Phenotype and Function in Hepatitis C Patients Undergoing Interferon-Free Therapy.
Perpiñán E; Pérez-Del-Pulgar S; Londoño MC; Mariño Z; Bartres C; González P; García-López M; Pose E; Lens S; Maini MK; Forns X; Koutsoudakis G
Front Immunol; 2020; 11():129. PubMed ID: 32161581
[No Abstract] [Full Text] [Related]
11. Ribavirin Improves NK Cell IFNγ Response During Sofosbuvir-based DAA Therapy in HCV-infected Liver Transplant Recipients.
Adenugba A; Hornung M; Weigand K; Peschel G; Junger H; Kupke P; Lang H; Marquardt JU; Zimmermann T; Geissler EK; Schlitt HJ; Werner JM
Transplantation; 2021 Oct; 105(10):2226-2238. PubMed ID: 33587435
[TBL] [Abstract][Full Text] [Related]
12. Association of NKG2A with treatment for chronic hepatitis C virus infection.
Harrison RJ; Ettorre A; Little AM; Khakoo SI
Clin Exp Immunol; 2010 Aug; 161(2):306-14. PubMed ID: 20550548
[TBL] [Abstract][Full Text] [Related]
13. Successful Interferon-Free Therapy of Chronic Hepatitis C Virus Infection Normalizes Natural Killer Cell Function.
Serti E; Chepa-Lotrea X; Kim YJ; Keane M; Fryzek N; Liang TJ; Ghany M; Rehermann B
Gastroenterology; 2015 Jul; 149(1):190-200.e2. PubMed ID: 25754160
[TBL] [Abstract][Full Text] [Related]
14. Natural killer cells contribute to hepatic injury and help in viral persistence during progression of hepatitis B e-antigen-negative chronic hepatitis B virus infection.
Ghosh S; Nandi M; Pal S; Mukhopadhyay D; Chakraborty BC; Khatun M; Bhowmick D; Mondal RK; Das S; Das K; Ghosh R; Banerjee S; Santra A; Chatterjee M; Chowdhury A; Datta S
Clin Microbiol Infect; 2016 Aug; 22(8):733.e9-733.e19. PubMed ID: 27208430
[TBL] [Abstract][Full Text] [Related]
15. Impaired intrahepatic natural killer cell cytotoxic function in chronic hepatitis C virus infection.
Varchetta S; Mele D; Mantovani S; Oliviero B; Cremonesi E; Ludovisi S; Michelone G; Alessiani M; Rosati R; Montorsi M; Mondelli MU
Hepatology; 2012 Sep; 56(3):841-9. PubMed ID: 22431186
[TBL] [Abstract][Full Text] [Related]
16. Immunological changes in different patient populations with chronic hepatitis C virus infection.
Szereday L; Meggyes M; Halasz M; Szekeres-Bartho J; Par A; Par G
World J Gastroenterol; 2016 May; 22(20):4848-59. PubMed ID: 27239111
[TBL] [Abstract][Full Text] [Related]
17. Functions of liver natural killer cells are dependent on the severity of liver inflammation and fibrosis in chronic hepatitis C.
Fugier E; Marche H; Thélu MA; Macek Jílková Z; Van Campenhout N; Dufeu-Duchesne T; Leroy V; Zarski JP; Sturm N; Marche PN; Jouvin-Marche E
PLoS One; 2014; 9(4):e95614. PubMed ID: 24759660
[TBL] [Abstract][Full Text] [Related]
18. KLRG1+ natural killer cells exert a novel antifibrotic function in chronic hepatitis B.
Wijaya RS; Read SA; Schibeci S; Eslam M; Azardaryany MK; El-Khobar K; van der Poorten D; Lin R; Yuen L; Lam V; George J; Douglas MW; Ahlenstiel G
J Hepatol; 2019 Aug; 71(2):252-264. PubMed ID: 30905683
[TBL] [Abstract][Full Text] [Related]
19. Activation of natural killer cells by hepatitis C virus particles in vitro.
Farag MM; Weigand K; Encke J; Momburg F
Clin Exp Immunol; 2011 Sep; 165(3):352-62. PubMed ID: 21682720
[TBL] [Abstract][Full Text] [Related]
20. IL-26 is overexpressed in chronically HCV-infected patients and enhances TRAIL-mediated cytotoxicity and interferon production by human NK cells.
Miot C; Beaumont E; Duluc D; Le Guillou-Guillemette H; Preisser L; Garo E; Blanchard S; Hubert Fouchard I; Créminon C; Lamourette P; Fremaux I; Calès P; Lunel-Fabiani F; Boursier J; Braum O; Fickenscher H; Roingeard P; Delneste Y; Jeannin P
Gut; 2015 Sep; 64(9):1466-75. PubMed ID: 25183206
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]